Genprex Inc. [NASDAQ: GNPX] gained 14.24% or 0.44 points to close at $3.53 with a heavy trading volume of 2356819 shares. The company report on October 29, 2020 that Genprex Receives Conditional FDA Acceptance of Proprietary Name REQORSA™ for Lead Drug Candidate for Treatment of Non-Small Cell Lung Cancer.
Approval of new name marks important branding milestone and aligns with the program’s overall progress.
REQORSA immunogene therapy uses the company’s unique, proprietary ONCOPREX™ nanoparticle delivery system to deliver cancer-fighting genes.
It opened the trading session at $3.30, the shares rose to $3.58 and dropped to $3.12, the range by which the price of stock traded the whole day. The daily chart for GNPX points out that the company has recorded 55.51% gains over the past six months. However, it is still -1434.78% lower than its most recent low trading price.
If we look at the average trading volume of 886.42K shares, GNPX reached to a volume of 2356819 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Genprex Inc. [GNPX]:
Noble Capital Markets have made an estimate for Genprex Inc. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on April 29, 2019.
The Average True Range (ATR) for Genprex Inc. is set at 0.24 The Price to Book ratio for the last quarter was 5.12, with the Price to Cash per share for the same quarter was set at 0.57.
Trading performance analysis for GNPX stock
Genprex Inc. [GNPX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.06. With this latest performance, GNPX shares gained by 5.06% in over the last four-week period, additionally plugging by 55.51% over the last 6 months – not to mention a rise of 669.06% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GNPX stock in for the last two-week period is set at 49.87, with the RSI for the last a single of trading hit 53.21, and the three-weeks RSI is set at 49.93 for Genprex Inc. [GNPX]. The present Moving Average for the last 50 days of trading for this stock 3.64, while it was recorded at 3.29 for the last single week of trading, and 3.10 for the last 200 days.
Genprex Inc. [GNPX]: A deeper dive into fundamental analysis
Genprex Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 97.00 and a Current Ratio set at 100.70.
Genprex Inc. [GNPX]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Genprex Inc. posted -0.14/share EPS, while the average EPS was predicted by analysts to be reported at -0.2/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 30.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GNPX.
An analysis of insider ownership at Genprex Inc. [GNPX]
There are presently around $18 million, or 18.30% of GNPX stock, in the hands of institutional investors. The top three institutional holders of GNPX stocks are: BLACKROCK INC. with ownership of 1,827,777, which is approximately New of the company’s market cap and around 23.00% of the total institutional ownership; VANGUARD GROUP INC, holding 444,307 shares of the stock with an approximate value of $1.57 million in GNPX stocks shares; and STATE STREET CORP, currently with $1.53 million in GNPX stock with ownership of nearly New of the company’s market capitalization.
47 institutional holders increased their position in Genprex Inc. [NASDAQ:GNPX] by around 4,274,643 shares. Additionally, 4 investors decreased positions by around 66,060 shares, while 6 investors held positions by with 741,694 shares. The mentioned changes placed institutional holdings at 5,082,397 shares, according to the latest SEC report filing. GNPX stock had 31 new institutional investments in for a total of 3,171,438 shares, while 2 institutional investors sold positions of 48,041 shares during the same period.